tson's ABL as of February 28. 2015, consisted of loans of $980.0 million and letters of credit issued under the LOC sub-facility of $272.1 million. NAI ABL: The NAI ABL had no outstanding loan borrowings as of June 20, 2015 or February 28, 2015. The NAI ABL LOC sub- facility had outstanding issued letter

luding intellectual property), deposit accounts, scripts and prescription files, and certain related assets, and all proceeds of the foregoing (the "NAI ABL priority collateral"). The agreement requires annual principal payments of 1.0% of the original loan balance, paid quarterly. In conjunction with t